The breast reconstruction market generated a revenue of $584.7 million in 2021, and the market size will advance at a CAGR of 6.4% during the forecast period, to reach $1,018.6 million by 2030. This can be ascribed to the increasing awareness about breast reconstruction and technological advancement in implant procedures.
With the increasing number of breast cancer worldwide, many women are opting for reconstruction procedures to regain the original shape of their breasts after the mastectomy. For instance, around 400,000 women in the U.S. undergo breast implant surgeries every year.
Most patients undergo breast reconstruction in hospitals, as they choose to get it done immediately after the mastectomy, which is performed with utmost care in hospitals. Moreover, it becomes really important to get breast reconstruction done under the supervision of breast cancer surgeons, oncology treatment teams, and many other specialists, which becomes easy to get them in hospitals under the same roof. Moreover, in hospitals, patients can get back to their normal life more quickly. Thus, the category holds the largest market share.
The demand for immediate breast reconstruction after mastectomy has increased over the past decade, as it has become a standard of care following mastectomy for cancer. This is ascribed to its improved esthetic and psychologic outcomes achieved with this technique. Moreover, this method allows to perform mastectomy and breast reconstruction on patients at the same time to eliminate multiple surgeries. Thus, the category dominates the market.
With the increase in the number of breast surgeries and technological advancements in medical devices, the demand for breast implants among women who underwent mastectomy is rising. Moreover, key players in the market are continuously innovating implants. For instance, in December 2020, Establishment Labs Holdings Inc. received a CE mark for its next-generation Motiva Ergonomix2 silicone breast implant platform, which is used for breast aesthetics and reconstruction.
Europe holds the second-largest share in the breast reconstruction market. In Europe, Germany contributed the largest share to the regional market in 2021. This is because, in the country, 75,000 women are diagnosed with breast cancer annually. With the increasing awareness regarding breast reconstruction, approximately 8,000 breast reconstruction procedures are performed in Germany every year, which has boosted the market growth in the country.
Key players in the breast reconstruction market have been involved in strategic developments, such as product launches and approvals, to remain competitive. For instance:
Some of the major players in the breast reconstruction market include Allergan, GC Aesthetics, Guangzhou Wanhe Plastic Materials Co. Ltd., RTI Surgical Holdings, Groupe Sebbin SAS, Ideal Implant Incorporated, Mentor Worldwide LLC, Laboratoires Arion, POLYTECH Health and Aesthetics GmbH, Shanghai Kangning Medical Device Co. Ltd., and Sientra Inc.